| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.3 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.3 |